Headlines

Screening for Liver Disease in Type 2

Non-alcoholic fatty liver disease (NAFLD) originates from fat accumulation in the liver and can potentially lead to scarring of the tissue, cirrhosis, and liver cancer. It is known as a component of metabolic syndrome, which is often related to type 2 diabetes. Currently, there are no recommendations for standard NAFLD screenings in people with type […]

Immunosuppressive Medication Shows Potential for Type 1 Treatment

Golimumab is a human antibody that is used as an immunosuppressive drug (brand name Simponi) and is approved for the treatment of several autoimmune conditions, including ulcerative colitis. Researchers investigated whether golimumab could preserve beta-cell function in young people newly diagnosed with type 1 diabetes. Read more

Heart Failure in Type 2 Diabetes

The risk of developing heart failure in patients with type 2 diabetes is double for men and triple for women, compared to patients who do not have diabetes. Heart failure is not the most common comorbid condition in diabetes patients, but a 17-year long nationwide real-life cohort study found that it is the most fatal.  Read […]

Eating Too Many Eggs Could Lead to Diabetes

Research conducted by the University of South Australia, the China Medical University, and Qatar University says that too much egg consumption can increase your risk of diabetes. The researchers used data from 1991 to 2009 to assess egg consumption in a large number of Chinese adults, and found that people who regularly consumed one or […]

Could Diabetes Drug Sitagliptin Help Treat COVID-19?

Some research has suggested that inhibiting the protein DPP-4, which is produced by the human body, could provide benefit to patients infected with COVID-19. Sitagliptin is a diabetes drug in the DPP-4 inhibitor class that has also shown anti-inflammatory and immunoregulatory effects. Researchers investigated whether sitagliptin could help treat hospitalized COVID patients with type 2 […]

Why Patients with Type 2 Need Early Treatment for Heart Risk

Researchers looked at 5 risk factors for heart disease: blood pressure, smoking, cholesterol, triglycerides, and blood glucose, and found that most people with type 2 did not have all 5 risk factors within target range, and even those who had the 5 factors under control still had higher risk for cardiovascular disease and heart failure. […]

Hybrid Closed-Loop Systems and Insulin Variability in Children

Young children with type 1 diabetes often have greater insulin variability than do adults, which can lead to more complications and quality of life issues. Researchers investigated whether hybrid closed-loop devices, which deliver insulin automatically by using an algorithm that sensors glucose values in real-time, can help. Read more

Protein Screened in Pregnancy May Also Show Gestational Diabetes Risk

Researchers say that low levels of a protein, pregnancy-associated plasma protein A (PAPPA), that is commonly seen in screening tests for chromosomal disorders in the first trimester of pregnancy is associated with adipose tissue remodeling, glucose resistance and gestational diabetes mellitus in pregnant women. The protein levels could potentially be used as both a diagnostic […]

Type 1 Can Affect Children’s Cognitive Development

Because children’s brains are growing, they are more susceptible to interference with glucose production and metabolic breakdown, which has several adverse effects. Glucose in the brain is essential to its proper functioning, as the brain requires glucose to incite and feed brain cells. Read more

Do You Know These Diabetes Myths?

As diabetes becomes more prevalent, many myths and misconceptions about it continue to circulate — that eating sugar causes it, that only people with obesity can develop diabetes, and many more. How many of these common myths have you encountered? Read more

Should Younger People Be Screened for Type 2 Diabetes?

Current guidelines for type 2 diabetes recommend screening in patients without symptoms of diabetes only if they are older than 40 years of age, and have obesity or overweight. However, a new study urges that screening at-risk patients between 18 and 39 years old would result in better treatment and cost effectiveness. Read more

COVID-19 Neurological Risks in Diabetes Patients

People with diabetes or high blood pressure who contract COVID-19 may be at greater risk of developing neurological complications such as bleeding in the brain and stroke, according to an ongoing study. Read more

Being Physically Active Can Boost Your Immune Response

Physical activity can boost our immune system and response to viruses, lower the stress associated with being in a pandemic, and treat many pre-existing health conditions that are associated with a higher risk of complications or death from COVID-19, according to diabetes exercise expert Dr. Sheri Colberg. Read more

Celebrating Thanksgiving with Diabetes in 2020

Today is the Thanksgiving holiday in the United States. For many people with diabetes, it can be a challenge to balance good diabetes management and a holiday that centers around abundant food. This is added to the stress this year of the global pandemic. With careful planning, it is still possible to enjoy your favorite […]

Assessing Metformin in the Diabetes Landscape

Metformin is the standard first medication treatment of choice for people newly diagnosed with type 2 diabetes. A group of researchers decided to examine whether metformin, which this year celebrates its 63rd anniversary as a type 2 diabetes treatment, continues to earn its spot as a key member of the diabetes medication “All-Star Team.” Read more

Combining a Fitbit Device with Diabetes Management App Yields Benefits

A study in Taiwan found the use of a diabetes management app called Health2Sync in combination with Fitbit wearable devices can help users control and better manage the symptoms of type 2 diabetes. Read more

The Consequences of Polypharmacy in the Elderly

Many older patients with type 2 diabetes deal with polypharmacy — taking multiple medications for their diabetes and other conditions. Polypharmacy can be burdensome in various ways, including multiple side effects of the various medications. Researchers investigated whether the use of polypharmacy put elderly patients at increased risk for hospitalization, falls, and death from all […]

Can Vitamin D Supplementation Fight COVID-19?

Some studies have suggested that low levels of vitamin D, a vitamin which is produced in the body in response to sunlight exposure, might increase the risk of catching coronavirus and then becoming seriously ill from it.However, other studies say vitamin D plays no role in the virus, so experts are divided. Read more

Sotagliflozin and Chronic Kidney Disease

A recent phase 3 clinical trial on the diabetes drug sotagliflozin, an SGLT2 inhibitor, found it had favorable results for people living with severe renal impairment / chronic kidney disease.  Read more

Mental Health: Type 1 and “Diabetes Burnout”

Many people who have been diagnosed with type 1 diabetes are overwhelmed by the daily physical and mental challenges of managing the condition. This can result in “diabetes burnout,” a dangerous condition where patients are so overwhelmed they neglect to manage their insulin, glucose testing and food choices adequately. Read more



Other News

ACLS Class

  • Get ACLS and PALS certified online with ACLSclass.com’s fast programs.
  • Health Partner

Warning: Undefined variable $maxitems in /var/www/html/diabetesnews.com/wp-content/themes/dn_default/functions.php on line 188